Cargando…
501P A prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19
Autores principales: | Halabi, S., Luo, B., Dzimitrowicz, H., Hwang, C., Wise-Draper, T.M., Labaki, C., McKay, R.R., Ruiz, E., Rangel-Escareño, C., Farmakiotis, D., Griffiths, E.A., Jani, C.T., Accordino, M., Friese, C., Wulff-Burchfield, E., Puc, M., Yu, P., Topaloglu, U., Mishra, S., Warner, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472539/ http://dx.doi.org/10.1016/j.annonc.2022.07.629 |
Ejemplares similares
-
COVID-19 vaccination and breakthrough infections in patients with cancer
por: Schmidt, A.L., et al.
Publicado: (2022) -
Dictionary of 501 Spanish Verbs
por: Kendris, C.
Publicado: (1971) -
502P Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer
por: Bakouny, Z., et al.
Publicado: (2022) -
Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma
por: Johnson, Douglas B., et al.
Publicado: (2023) -
CompTIA Security+ SY0-501 review guide: exam SY0-501
por: Stewart, James M
Publicado: (2018)